Practical considerations in anticonvulsant therapy - Part 2

M. C. Meyer, J. Cloyd, W. R. Garnett, G. L. Holmes, J. R. Schiffer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Epilepsy is, for many patients, a lifeling condition that requires treatment with powerful drugs whose doses must be carefully titrated to avoid both breakthrough seizures and toxicity. The medication regimens used to treat epilepsy are further complicated by the fact that most seizure medications are metabolized in the liver and have the potential for serious pharmacokinetic drug-drug interactions with many other medications. Successful management of epilepsy requires a high degree of cooperation among the patient, the pharmacist, and the treating physician. Such cooperation can ensure that the appropriate treatment and drug preparation are selected, compliance is maintained, and dangerous drug-drug interactions are avoided.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalAmerican pharmacy
Volume35
Issue number9
DOIs
StatePublished - Jan 1 1995

Fingerprint Dive into the research topics of 'Practical considerations in anticonvulsant therapy - Part 2'. Together they form a unique fingerprint.

Cite this